{"id":28276,"date":"2016-10-06T13:26:18","date_gmt":"2016-10-06T11:26:18","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=28276"},"modified":"2016-10-06T19:23:43","modified_gmt":"2016-10-06T17:23:43","slug":"novartis-chiude-a-zurigo-e-shanghai-ma-apre-nuovi-impianti-a-basilea-e-cambridge","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-chiude-a-zurigo-e-shanghai-ma-apre-nuovi-impianti-a-basilea-e-cambridge\/","title":{"rendered":"Novartis closes in Zurich and Shanghai but opens new plants in Basel and Cambridge"},"content":{"rendered":"<p class=\"site-block__title\">A &quot;global strategy&quot;, as the company has defined it&quot; which will cause 175 redundancies. Employees in the Singapore center will be transferred to California to continue their malaria studies.<\/p>\n<p class=\"site-block__title\">Of <a href=\"http:\/\/www.aboutpharma.com\/blog\/2016\/10\/06\/novartis-chiude-a-zurigo-e-shanghai-apre-nuovi-impianti-a-basilea-e-cambridge\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Aboutpharma Online editorial staff \u2013 October 6, 2016<\/span><\/a><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"https:\/\/s.yimg.com\/ny\/api\/res\/1.2\/gLN7d2x7cefBbiawTfAmng--\/YXBwaWQ9aGlnaGxhbmRlcjtzbT0xO3c9NDUwO2g9MjU5O2lsPXBsYW5l\/http:\/\/media.zenfs.com\/en_us\/News\/Reuters\/2016-05-19T142409Z_1_LYNXNPEC4I12C_RTROPTP_2_NOVARTIS.JPG.cf.jpg\" alt=\"Risultati immagini per novartis zurich\" width=\"327\" height=\"188\" \/>Novartis<\/strong> announced yesterday that it will close research centers in <strong>Swiss<\/strong> And <strong>China<\/strong>. The decision is due to a cost reduction and efficiency plan of the company. Furthermore, continues the pharmaceutical company, the<strong>Singapore Institute of Tropical Diseases will be moved to California<\/strong>. \u201cThe move is part of a global strategy \u2013 said the multinational \u201cbecause we want to merge the infectious disease research team with that of tropical diseases\u201d.<\/p>\n<p>But Novartis&#039; intentions do not envisage any abandonment of Switzerland, on the contrary. Future business plans predict <strong>two centers of excellence for biotherapy<\/strong>, one to <strong>Basel<\/strong> and one to <strong>Cambridge<\/strong> (Massachusetts), with an operation of approximately one and a half billion. \u201cThe creation of a unified research group will be integrated with the research groups of the Institute for Biomedical Research.<\/p>\n<p>Closures and movements will not be painless. Seventy-three employees will be laid off from the Esbatech facility near Zurich, while the <strong>eighty-four researchers from Singapore will be relocated to California<\/strong>. In addition there are also the <strong>eighteen<\/strong> Shanghai China facility locations. According to the company, however, the creation of the Basel and Cambridge centers will allow for twenty-five new positions.<\/p>\n<p>This announcement follows the one made this summer when <strong>Novartis<\/strong> said it was closing its cell therapy unit, eliminating 120 jobs, while beefing up its oncology department.<\/p>\n<p>Related news: <a href=\"http:\/\/www.teleborsa.it\/News\/2016\/10\/06\/pfizer-dice-addio-alla-storica-sede-di-new-york-257.html#.V_aIHuCLSUk\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Pfizer bids farewell to historic New York headquarters<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Una &#8220;strategia globale&#8221;, cos\u00ec \u00e8 stata definita dall&#8217;azienda&#8221; che causer\u00e0 175 esuberi. I dipendenti del centro di Singapore saranno, invece, trasferiti in California per continuare gli studi sulla malaria. di Redazione Aboutpharma Online &#8211;\u00a06 ottobre 2016 Novartis ha annunciato ieri che chiuder\u00e0 i centri di ricerca in Svizzera e Cina. La decisione \u00e8 dovuta a &hellip;<\/p>","protected":false},"author":4,"featured_media":28279,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[56],"class_list":["post-28276","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-cina"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=28276"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28276\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/28279"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=28276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=28276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=28276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}